MicroPort CardioFlow Medtech Corporation (HKG:2160)

HKG:2160 Revenue

In the year 2025, MicroPort CardioFlow Medtech had annual revenue of $57.04M USD with 12.28% growth. MicroPort CardioFlow Medtech had revenue of $12.14M in the quarter ending December 31, 2025, with 20.04% growth. That makes MicroPort CardioFlow Medtech the 27,010th largest company in the world by revenue and 1,605th in Hong Kong.

• Revenue: $57.04M
• Revenue Growth: +12.28%
• P/S Ratio: 3.67
• Revenue / Employee: $40.31K
• Employees: 1,415
• Market Cap: 1.63B HKD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• structural heart disease business 51.31M 89.9%
• Crm Business 5.73M 10.1%

By Geography

Chart

• The People's Republic of China 40.15M 70.4%
• Europe, Middle East, and Africa 12.39M 21.7%
• Other Countries 2.32M 4.1%
• Asia (Excluding The PRC) 2.17M 3.8%
• North America 21.00K 0.0%

Fiscal year ended Dec 31, 2025 See the full HKG:2160 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	57.04M	6.24M	12.28%
Dec 31, 2024	50.81M	3.39M	7.15%
Dec 31, 2023	47.41M	11.02M	30.28%
Dec 31, 2022	36.40M	4.78M	15.13%
Dec 31, 2021	31.61M	15.69M	98.57%

Data Source: S&P Global Market Intelligence Last updated: Apr 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error